Revolutionizing Cervical Cancer Prevention: New Guidelines and Diagnostic Test Offer Personalized Care
ASCCP and NCI Publish Guidance in the Journal of Lower Genital Tract Disease; BD Onclarity HPV Assay Identifies Risk by HPV Type for Tailored Management CLARKSBURG, MARYLAND / ACCESS Newswire / ...
Global Blood Micro-Sampling Medical Devices Market is expected to reach revenue of USD 3,272.6 Mn by 2033, at 5.3% CAGR: Dimension Market Research.
Advancements and Projections in the Global Blood Micro-Sampling Medical Devices Market: Insights, Trends, Opportunities, and ...
Zawya2d
BD to showcase medtech innovations and signature programmes at Arab Health 2025
Company will spotlight sustainable solutions to enhance patient safety, workforce well-being, and care delivery efficiency ...
CSOonline1d
CISA warns of critical, high-risk flaws in ICS products from four vendors
CISA released 11 advisories for serious vulnerabilities in industrial control systems products from Schneider Electric, ...
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases BD Completed $750 Million Repurchase To Date In FY25
The company also announced it repurchased $750 million in BD stock to date in fiscal 2025. In addition, the board has authorized the company to repurchase up to 10 million shares of BD common stock in ...
BetterWay Blood Testing Named SXSW Innovation Awards Finalist in Health & Biotech Category
Babson Diagnostics, a science-first healthcare technology company, today announced that BetterWay™ blood testing is a ...
BD announces dividend and additional share repurchase authorization
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology firm with a market ...
Zacks.com on MSN5d
BD Stock Rises on Biosero Deal for AI-Powered Robotic Cytometry Tech
Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of ...
Piper Sandler Reaffirms Their Buy Rating on Becton Dickinson (BDX)
In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Becton Dickinson (BDX – Research Report), with a price ...
Point of Care Diagnostics Market to Hit USD 22.63 Billion by 2029 with 8.5% CAGR | MarketsandMarkets
The global point of care diagnostics market valued at US$ 14.26 billion in 2023, is forecasted to grow at a robust CAGR of 8.5%, reaching US$ ...
Becton, Dickinson and Company (NYSE:BDX) Approves Stock Repurchase Plan
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) announced that its board has authorized a share buyback program on ...